Oligospermia

A condition of suboptimal concentration of SPERMATOZOA in the ejaculated SEMEN to ensure successful FERTILIZATION of an OVUM. In humans, oligospermia is defined as a sperm count below 20 million per milliliter semen.

Drugs by status

Phase 4 trials (4)

bacille calmette-guerin
urofollitropin
tribulus terrestris
gulingji

Phase 3 trials (6)

folic acid
myoinositol
anastrozole
walnut
multivitamins
letrozole

Phase 2 trials (6)

vitamin e
chandrakanthi choornam
tamoxifen
clomifene
lisinopril
Mesenchymal Stem Cell Secretome

Phase 1 trials (2)

allorx stem cells®
stsp-0902

Other trials (2)

ramipril
omega-3 fatty acids

Organizations

Organization Involved with Phase 4 Indications (2)

Livzon Pharmaceutical Group Inc.
Peking University

Organization Involved with Phase 3 Indications (7)

AGUNCO Obstetrics and Gynecology Centre
Cedars-Sinai Medical Center
KK Women's and Children's Hospital
University of Valencia
University of California, Los Angeles
University of Catania
University of Utah

Organization Involved with Phase 2 Indications (3)

National institute of Siddha
Tamil Nadu Dr.M.G.R.Medical University
University of Nigeria

Organization Involved with Other Experimental Indications (5)

Cornell University
University of Copenhagen
Hospitalsenhed Midt
The Cleveland Clinic
Jinlin University